Evaluation of Surgical Site Infection in Breast Cancer Surgery: An Observational Study
Creators
- 1. Assistant Professor, Department of Urology & Kidney Transplantations, SCB Medical College & Hospital, Cuttack
- 2. Assistant Professor, Department of General Medicine, SCB MCH, Cuttack
- 3. JR, Department of Plastic and Reconstructive Surgery, SCB MCH, Cuttack
- 4. Assistant Professor, Department of General Surgery, SCB Medical College & Hospital, Cuttack
Description
Background: The purpose of this study was to evaluate postoperative site infections in breast cancer surgery patients. Materials and Methods: The current investigation was carried out in the Departments of General Surgery, Department of plastic and reconstructive surgery and Microbiology at SCB Medical College and Hospital, Cuttack. A total of 100 participants were registered. The participants were divided into four groups based on the type of breast surgery they had: mastectomy (without breast-saving techniques), breast-conserving surgery, breast reconstruction using the Lattismus Dorsi (LD) flap method, and subcutaneous amputation with simultaneous reconstruction using an artificial prosthesis. The surgical site infection was assessed. All of the findings were analyzed using SPSS software. Results: Overall, 11 percent of participants had SSI. The proportion of patients identified with surgical site infection (SSI) in each treatment group showed that those who had subcutaneous amputation with contemporaneous repair using an artificial prosthesis had a significantly higher incidence (27.2%). Conclusion: Surgical site infection (SSI) offers a substantial issue, justifying a focus on preventative measures.
Abstract (English)
Background: The purpose of this study was to evaluate postoperative site infections in breast cancer surgery patients. Materials and Methods: The current investigation was carried out in the Departments of General Surgery, Department of plastic and reconstructive surgery and Microbiology at SCB Medical College and Hospital, Cuttack. A total of 100 participants were registered. The participants were divided into four groups based on the type of breast surgery they had: mastectomy (without breast-saving techniques), breast-conserving surgery, breast reconstruction using the Lattismus Dorsi (LD) flap method, and subcutaneous amputation with simultaneous reconstruction using an artificial prosthesis. The surgical site infection was assessed. All of the findings were analyzed using SPSS software. Results: Overall, 11 percent of participants had SSI. The proportion of patients identified with surgical site infection (SSI) in each treatment group showed that those who had subcutaneous amputation with contemporaneous repair using an artificial prosthesis had a significantly higher incidence (27.2%). Conclusion: Surgical site infection (SSI) offers a substantial issue, justifying a focus on preventative measures.
Files
IJPCR,Vol16,Issue2,Article102.pdf
Files
(300.5 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:5d7b929de10939988cf1a28b16f5f578
|
300.5 kB | Preview Download |
Additional details
Dates
- Accepted
-
2024-01-26
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/16/IJPCR,Vol16,Issue2,Article102.pdf
- Development Status
- Active
References
- 1. Bratzler D.W., Houck P.M. Antimicrobial prophylaxis for surgery: An advisory statement from the national surgical infection prevention project. Clin. Infect. Dis. 2004; 38:1706–1715. 2. Mangram A.J., Horan T.C., Pearson M.L., Silver L.C., Jarvis W.R. Guideline for prevention of surgical site infection. Infect. Control Hosp. Epidemiol. 1999; 20:247–280. 3. Pałubicka A., Wekwejt M., Świeczko-Żurek B., Zieliński J. Powikłania po rekonstrukcji piersi: Problem zakażeń i strategii prewencyjnej—Przegląd literaturowy. Chir. Plast. I Oparzenia. 2017;5: 89–97. 4. Gil-Londoño J.C., Nagles-Pelaez J.A., MayaSalazar W.A., Madrid J., Maya-Restrepo M.A., Agudelo-Perez R.A., Ochoa 5. J. Surgical site infection after breast cancer surgery at 30 days. Infectio. 2017; 21:96–101. 6. Zhao X., Wu X., Dong J., Liu Y., Zheng L., Zhang L. A Meta-analysis of Postoperative Complications of Tissue Expander/Implant Breast Reconstruction Using Acellular Dermal Matrix. Aesthetic Plast. Surg. 2015; 39:892– 901. 7. Olsen M.A., Lefta M., Dietz J.R., Brandt K.E., Aft R., Matthews R., Mayfield J., Fraser V.J. Risk Factors for Surgical Site Infection after Major Breast Operation. J. Am. Coll. Surg. 2008; 207:326–335. 8. Indelicato D, Grobmyer SR, Newlin H, et al. Association between operative closure type and acute infection, local recurrence, and disease surveillance in patients undergoing breast conserving therapy for early-stage breast cancer. Surgery. 2007; 141(5):645–653. 9. Prospero E, Cavicchi A, Bacelli S, et al. Surveillance for surgical site infection after hospital discharge: a surgical procedure-specific perspective. Infect Control Hosp Epidemiol. 2006; 27(12):1313–1317. 10. Edwards JR, Peterson KD, Mu Y, et al. National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009. Am J Infect Control. 2009; 37(10):783–805. 11. Nahabedian MY, Tsangaris T, Momen B, et al. Infectious complications following breast reconstruction with expandersand implants. Plast Reconstr Surg. 2003; 112(2):467–476. 12. Ban KA, Minei JP, Laronga C, et al.. American College of Surgeons and Surgical Infection Society: Surgical Site Infection Guidelines, 2016 Update. J Am Coll Surg. 2017; 224:59– 74. 13. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Centers for disease control and prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control. 1999; 27:97–132; quiz 133. 14. Wilson AP, Treasure T, Sturridge MF, Grüneberg RN. A scoring method (ASEPSIS) for postoperative wound infectionsfor use in clinical trials of antibiotic prophylaxis. Lancet. 1986; 1:311–313. 15. Indelicato D, Grobmyer SR, Newlin H, et al.. Association between operative closure type and acute infection, local recurrence, and disease surveillance in patients undergoing breast conserving therapy for early-stage breast cancer. Surgery. 2007; 141:645–653. 16. Throckmorton A.D., Baddour L.M., Hoskin T.L., Boughey J.C., Degnim A.C. Microbiology of surgical site infections complicating breast surgery. Surg. Infect. (Larchmt) 2010;11:355–359. 17. Franchelli S., Pesce M., Baldelli I., Marchese A., Santi P., De Maria A. Analysis of clinical management of infected breast implants and of factors associated to successful breast pocket salvage in infections occurring after breast reconstruction. Int. J. Infect. Dis. 2018; 71:67– 72. 18. Palubicka A, Jaworski R, Wekwejt M, Swieczko-Zurek B, Pikula M, Jaskiewicz J, Zielinski J. Surgical Site Infection after Breast Surgery: A Retrospective Analysis of 5-Year Postoperative Data from a Single Center in Poland. Medicina (Kaunas). 2019 Aug 21; 55(9):512. 19. Louis, MY. Groupe de Prévention des Infections en Cancérologie (GPIC)., Lemarie, F. et al. O054: Surgical site infections (SSI) and risk factors in breast cancer surgery (BCS): French survey surviso 2011. Antimicrob Resist Infect Control 2 (Suppl 1), O54 (2013). 20. Cappelli S, Corallino D, Clementi M, Guadagni S, Pelle F, Puccica I, Barba M, Vici P, Sperduti I, Costantini M, Botti C. Surgical site infections in patients undergoing breast oncological surgery during the lockdown: An unexpected lesson from the COVID-19 pandemic. G Chir. 2022 Jul 25; 42(2):e02.